Cdc42: A New therapeutic target in drug-resistant multiple myeloma

被引：0
|
作者：
Thi Thuy Phuong Nguyen [1 ]
Chakrabart, Jayati [1 ]
Guo, Fukun [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
123.8
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cdc42: a new potential therapeutic target in colorectal cancer
    Gomez del Pulgar, T.
    Valdes-Mora, F.
    Bandres, E.
    Espina, C.
    Perez-Palacios, R.
    Illana, F. J.
    Cejas, P.
    Garcia-Cabezas, M. A.
    Feliu, J.
    Gonzalez-Baron, M.
    Garcia-Foncillas, J.
    Lacal, J. C.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S30 - S30
  • [2] Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma
    Nguyen, Phuong
    Chakrabarti, Jayati
    Li, Yuan
    Kalim, Khalid W.
    Zhang, Mengnan
    Zhang, Lin
    Zheng, Yi
    Guo, Fukun
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [3] SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
    Wu, Jian
    Zhang, Min
    Faruq, Omar
    Zacksenhaus, Eldad
    Chen, Wenming
    Liu, Aijun
    Chang, Hong
    [J]. BIOMARKER RESEARCH, 2021, 9 (01)
  • [4] SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
    Jian Wu
    Min Zhang
    Omar Faruq
    Eldad Zacksenhaus
    Wenming Chen
    Aijun Liu
    Hong Chang
    [J]. Biomarker Research, 9
  • [5] BET bromodomain degradation as a therapeutic strategy in drug-resistant multiple myeloma
    Matthews, Geoffrey M.
    Hu, Yiguo
    Sheffer, Michel
    Hengeveld, Paul J.
    Buckley, Dennis L.
    Bariteau, Megan A.
    Poarch, Haley
    Bradner, James E.
    Mitsiades, Constantine S.
    [J]. CANCER RESEARCH, 2016, 76
  • [6] Combined treatment for drug-resistant multiple myeloma?
    Burton, A
    [J]. LANCET ONCOLOGY, 2005, 6 (07): : 447 - 447
  • [7] Progress in the therapeutic inhibition of Cdc42 signalling
    Murphy, Natasha P.
    Mott, Helen R.
    Owen, Darerca
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2021, 49 (03) : 1443 - 1456
  • [8] Combination therapy for treating drug-resistant multiple myeloma
    Kim, Byung-Gyu
    Choi, Sung Hee
    Luo, George
    Kim, Seong-Jin
    Malek, Ehsan
    Driscoll, James
    Letterio, John
    [J]. JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [9] Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras-Related Cancers
    Aguilar, Byron J.
    Zhou, Huchen
    Lu, Qun
    [J]. CURRENT MEDICINAL CHEMISTRY, 2017, 24 (32) : 3485 - 3507
  • [10] Cdc42: new roads to travel
    Cerione, RA
    [J]. TRENDS IN CELL BIOLOGY, 2004, 14 (03) : 127 - 132
12345